Market Place
Sourcing Support
All News #Library
Biotech
Arrivent To Showcase Firmonertinib & ARR-002 At 2026 AACR Meeting
17 Mar 2026 //
GLOBENEWSWIRE
Arrivent Biopharma Reports Full Year 2025 Financial Results
05 Mar 2026 //
GLOBENEWSWIRE
Arrivent Appoints Brent S. Rice As Chief Commercial Officer
22 Sep 2025 //
GLOBENEWSWIRE
Arrivent Releases Final Firmonertinib Data in EGFR PACC Cancer
09 Sep 2025 //
GLOBENEWSWIRE
ArriVent Reports Positive Firmonertinib Data in Lung Cancer
23 Jun 2025 //
GLOBENEWSWIRE
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007
22 Jan 2025 //
PRESS RELEASE
Aarvik Therapeutics Announces Option Exercise By Partner ArriVent BioPharma
15 Aug 2024 //
BUSINESSWIRE
ArriVent licenses ADC from $100M biobuck deal with Aarvik
15 Aug 2024 //
FIERCE BIOTECH
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
06 Jun 2024 //
BIOSPACE
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 Jun 2024 //
GLOBENEWSWIRE
ArriVent brings in $175M for biotech’s second IPO of the year
26 Jan 2024 //
FIERCE BIOTECH
With one of biotech`s largest private rounds in a year, ArriVent enters PhIII
27 Mar 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.